Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Immedica Pharma Ab

Clinical trials sponsored by Immedica Pharma Ab, explained in plain language.

Not yet recruiting 1 Completed 2
Sort by
  • New hormone treatment shows promise for rare adrenal disorder

    Disease control Completed

    This study looked at the long-term safety of a medication called Chronocort in 76 people aged 16 and older with congenital adrenal hyperplasia (CAH), a condition where the body can't make enough cortisol. Researchers monitored for signs of over- or under-treatment, adrenal crises…

    Phase: PHASE3 • Sponsor: Immedica Pharma AB • Aim: Disease control

    Last updated Jun 27, 2026 14:00 UTC

  • New hope for babies with rare enzyme disorder: weekly shot shows promise

    Disease control Completed

    This study tested a weekly injection of pegzilarginase (Loargys) in 3 infants under 24 months old with arginase 1 deficiency, a rare genetic disorder that causes harmful buildup of arginine. The goal was to see if the drug is safe and can lower arginine levels in the blood. The t…

    Phase: PHASE3 • Sponsor: Immedica Pharma AB • Aim: Disease control

    Last updated Jun 27, 2026 12:36 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space